FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease
The FDA approved the first medication, to be used along with diet and exercise, for the treatment of patients with liver scarring due to fatty liver disease.
The FDA approved the first medication, to be used along with diet and exercise, for the treatment of patients with liver scarring due to fatty liver disease.
Supporters argue that it broadens trainee experience—while detractors say the burden of moving to a new placement every few months is too high. The clamour…
This JAMA Insights Clinical Update discusses the symptoms, diagnosis, and management of eosinophilic gastrointestinal diseases.
This JAMA Insights Clinical Update discusses the symptoms, diagnosis, and management of eosinophilic gastrointestinal diseases.
This cohort study evaluates the association between evacuation and health care outcomes among Florida assisted living residents exposed to Hurricane Irma.
This systematic review and meta-analysis evaluates the complication, emergency department, and hospital readmission rates associated with telemedicine vs conventional care in patients who underwent abdominal…
This cross-sectional study compared the characteristics of 340B hospitals that did not receive a lump sum payment with hospitals in the program that did receive…
One in three women under 50 is iron deficient. Learn more with the AMA on why that matters for your health and how to address…
The cross-regulation of metabolism and trafficking is not well understood for the vital sphingolipids and cholesterol constituents of cellular compartments. While reports are starting to…
Cancer cells exhibit significant alterations in their metabolism, characterised by a reduction in oxidative phosphorylation (OXPHOS) and an increased reliance on glycolysis, even in the…
The membrane composition of extracellular vesicles (EVs) largely reflects that of the plasma membrane of the cell of origin. We therefore hypothesized that EVs are…